Mr. Speaker, from the discussions at the last health ministers meeting, our understanding was that most provinces and territories did not incur additional costs, and we were able to cover by adding testing requirements.
Over the last year of this global shortage, we have seen incredible resourcefulness in managing the existing supply. For example, the medical community has shown great flexibility during this time by maximizing the use of available TC-99 and using alternative isotopes for certain tests.